APA (7th ed.) Citation

Li, C., Li, B., Liang, Y., Peng, R., Ding, Y., Xu, D., . . . Zhang, X. (2009). Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB. Journal of translational medicine, 7(1), 56. https://doi.org/10.1186/1479-5876-7-56

Chicago Style (17th ed.) Citation

Li, Chun-Yan, et al. "Higher Percentage of CD133+ Cells Is Associated with Poor Prognosis in Colon Carcinoma Patients with Stage IIIB." Journal of Translational Medicine 7, no. 1 (2009): 56. https://doi.org/10.1186/1479-5876-7-56.

MLA (9th ed.) Citation

Li, Chun-Yan, et al. "Higher Percentage of CD133+ Cells Is Associated with Poor Prognosis in Colon Carcinoma Patients with Stage IIIB." Journal of Translational Medicine, vol. 7, no. 1, 2009, p. 56, https://doi.org/10.1186/1479-5876-7-56.